|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cutting edge: reactiveoxygen species inhibitors block priming, but not activation, of theNLRP3 inflammasome显示文摘 | Bauemfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 2 | Cutting edge:reactive oxygen species inhibitors block priming, but notactivation, of the NLRP3 inflammasome 显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 3 | Role of body mass index and gestational weight gain in breastfeeding outcomes显示文摘 | BARTOK C J SCHAEFER E W BEILER J S | 2012 | Breastfeed Med2012，7，6： | 1 |
| 4 | Automated NeuropsychologicalTest Battery(CANTAB)in mild cognitive impairment and in Alzhei-mer’s disease显示文摘 | Egerhazi A Berecz R Bartok E | 2007 | Prog Neuropsychopharmacol Biol Psychiatry2007，31，3： | 1 |
| 5 | Inflammasomes : cur- rent understanding and open questions 显示文摘 | Bauemfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 6 | Sex differences in opioid antinociception 显示文摘 | Bartok R E Craft R M | 1997 | J Pharmacol Exp Ther1997，282，： | 1 |
| 7 | Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome 显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 8 | Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome 显示文摘 | Bauemfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 9 | Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 10 | Inflammasomes: current understanding and open questions显示文摘 | BAUERNFEIND F ABLASSER A BARTOK E etal | 2011 | Cell Mol Life Sci2011，68，： | 1 |
| 11 | Inflammasomes:current understanding and open questions显示文摘 | Bauernfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 12 | Inflammasomes : cur- rent understanding and open questions 显示文摘 | Bauemfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 13 | Inflammasomes : current understanding and open questions显示文摘 | Bauernfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 14 | Cutting edge:Reactive oxygen species inhibitors block priming,but not activation,of the NLRP3 inflammasome显示文摘 | Bauernfeind F G Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 15 | Inflammasomes:currentunderstanding and open questions显示文摘 | Bauernfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 16 | Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome 显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 17 | Sex differences in opioid antinociception 显示文摘 | Bartok R E Craft R M | 1997 | J Pharmacol Exp Ther1997，282，： | 1 |
| 18 | Cutting edge:reactiveoxygen species inhibitors block priming,but not activation,of theNLRP3 inflammasome显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
| 19 | Inflamma- somes: current understanding and open questions显示文摘 | Bauernfeind F Ablasser A Bartok E | 2011 | Cell Mol Life Sci2011，68，5： | 1 |
| 20 | Cutting edge:reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome显示文摘 | Bauernfeind F Bartok E Rieger A | 2011 | J Immunol2011，187，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员